Gastrointestinal transplant complications
Research activity includes acute graft versus host disease, with a focus on steroid-refractory gastrointestinal aGVHD affecting the lower digestive tract.
- Immune-mediated intestinal injury
- Gastrointestinal inflammation
- Post-transplant complications
The sponsor’s studies in this area are centered on gastrointestinal symptoms and clinical safety in patients with severe transplant-related bowel involvement.
Short bowel syndrome
Another key area is short bowel syndrome, including short bowel syndrome with intestinal failure, where the clinical focus is on digestive support and long-term management.
- Intestinal failure
- Nutritional absorption
- Chronic gastrointestinal care
These trials address persistent malabsorption and the ongoing clinical burden associated with reduced bowel length.
Healthy volunteer pharmacology
The sponsor also supports studies in healthy adults to examine the bioavailability and comparative formulation performance of investigational therapy.
- Subcutaneous administration
- Pharmacokinetics
- Formulation comparison
This area reflects interest in how the therapy is absorbed and handled in the body under controlled clinical conditions.
Peptide-based gastrointestinal therapy
Across its portfolio, the sponsor is focused on apraglutide, a GLP-2 analog studied for disorders involving impaired intestinal function and bowel recovery.
- Intestinal repair
- Digestive tract support
- Therapeutic peptide development
The research spans both rare gastrointestinal diseases and supportive treatment strategies for patients with significant bowel dysfunction.
